Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 6/20 | 0.55 |
| ▸ | GRPR | P30550 | 6/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.49 |
| ▸ | GLP1R | P43220 | 3/20 | 0.47 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31494985 | 0.95 | REN (0.53) | RENGRPROPRM1OPRD1GLP1R | |
| SCHEMBL29473455 | 0.95 | GRPR (0.57) | RENGRPROPRM1OPRD1NPBWR1 | |
| SCHEMBL38660507 | 0.94 | GRPR (0.58) | GRPROPRM1OPRD1GLP1RNPBWR1 | |
| SCHEMBL30816315 | 0.92 | GRPR (0.63) | RENGRPRGLP1R | |
| SCHEMBL31223150 | 0.90 | GRPR (0.61) | GRPROPRM1OPRD1GLP1R | |
| SCHEMBL16716014 | 0.90 | GRPR (0.57) | RENGRPR | |
| SCHEMBL20764506 | 0.90 | GRPR (0.59) | GRPROPRM1OPRD1GLP1R | |
| SCHEMBL30398505 | 0.89 | GRPR (0.64) | GRPR | |
| SCHEMBL12767725 | 0.89 | GRPR (0.58) | RENGRPRNPBWR1 | |
| SCHEMBL30118088 | 0.89 | GRPR (0.62) | RENGRPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4188457-A1 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | Orano Med (FR) | 2023-06-07 | — | — | EP | claimed |
| WO-2022063850-A1 | CONJUGATE OR ITS SALT COMPRISING A GASTRIN-RELEASING PEPTIDE RECEPTOR ANTAGONIST AND USES THEREOF | ORANO MED (FR) | 2022-03-31 | — | — | WO | claimed |